Unigene Claims $64.2M Liabilities In Ch. 7 Petition

By Kathryn Brenzel (July 3, 2013, 4:58 PM EDT) -- New Jersey-based Unigene Laboratories filed for Chapter 7 bankruptcy on Tuesday, declaring $64.2 million in liabilities after defaulting on repayments to a private equity firm and the company's founders.

The filing follows a troubling year for the drugmaker, including a loss of revenue from its osteoporosis nasal spray, Fortical, with warnings earlier this year that if the company failed to restructure debt owed to Victory Park Capital and its founders, it wouldn't be able to continue operations, according to regulatory filings.

The company lists $394,022 in assets and $64.2 million in liabilities — most of which is debt owed to VPC,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents

Related Sections

Law Firms


Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!